THE USE OF REAL-WORLD EVIDENCE IN HTA OF CLASS III MEDICAL DEVICES IN EUROPE

被引:0
|
作者
Klein, P. [1 ]
de Groot, S. [2 ]
Blommestein, H. M. [2 ]
Pongiglione, B. [3 ]
Torbica, A. [4 ]
Al, M. J. [2 ]
机构
[1] Inst Med Technol Assessment, Rotterdam, Netherlands
[2] Erasmus Univ, Rotterdam, Netherlands
[3] SDA Bocconi Sch Management, Milan, Italy
[4] Bocconi Univ, Milan, MI, Italy
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
RW3
引用
收藏
页码:S758 / S758
页数:1
相关论文
共 50 条
  • [21] How to Deal with the Inevitable: Generating Real-World Data and Using Real-World Evidence for HTA Purposes - From Theory to Action
    Oortwijn, Wija
    Sampietro-Colom, Laura
    Trowman, Rebecca
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2019, 35 (04) : 346 - 350
  • [22] The use of Real-World Data (RWD) by Health Technology Assessment (HTA) agencies
    Karen, K.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31 : 218 - 218
  • [23] Development of a real-world evidence platform for MPS III
    Cotter, Kristina
    Fernandez, Charlene
    Simpson, Brenda
    Yu, Nancy
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S42 - S43
  • [24] Evolving Use of Real-World Evidence for Devices: Good for Patients, Good for Policy Makers
    Mullins, C. Daniel
    VALUE IN HEALTH, 2019, 22 (07) : 751 - 753
  • [25] Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies
    Makady, Amr
    ten Ham, Renske
    de Boer, Anthonius
    Hillege, Hans
    Klungel, Olaf
    Goettsch, Wim
    VALUE IN HEALTH, 2017, 20 (04) : 520 - 532
  • [26] THE VALUE OF REAL-WORLD EVIDENCE (RWE) IN MELANOMA IN HEALTH TECHNOLOGY ASSESSMENT (HTA) APPRAISALS
    Shah, R.
    Gautam, R.
    Rai, M. K.
    Prasanna, R.
    VALUE IN HEALTH, 2022, 25 (12) : S317 - S317
  • [27] REAL-WORLD EVIDENCE IN MULTIPLE SCLEROSIS (MS): HTA DECISION-MAKING INFLUENCER OR NOT?
    Nanda, S.
    Jindal, S.
    Rohillla, A.
    Mahajan, S.
    Saharia, P.
    VALUE IN HEALTH, 2022, 25 (12) : S344 - S344
  • [28] EVALUATING THE HTA IMPACT OF REAL-WORLD EVIDENCE FROM FORMAL ORPHAN DRUG REGISTRIES
    Bustamante, M. M. D.
    Yang, E.
    Anderson, K.
    VALUE IN HEALTH, 2020, 23 : S347 - S347
  • [29] Evaluating the quality of medical evidence in real-world contexts
    Jones, Andrew
    Steel, Daniel
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2018, 24 (05) : 950 - 956
  • [30] Real-world study: from real-world data to real-world evidence
    Wen, Yi
    TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1